Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Connor Prosty

Showing results (21-30 of 56) with videos related to

Pageof 6
Sort By:
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|July 23, 2024
Revisiting the Evidence Base That Informs the Use of Adjunctive Therapy for Enterococcus faecalis Endocarditis: A Systematic Review and Meta-AnalysisConnor Prosty, Mark Sorin, Khaled Katergi, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|April 7, 2024
Comparative efficacy and safety of Pneumocystis jirovecii pneumonia prophylaxis regimens for people living with HIV: a systematic review and network meta-analysis of randomized controlled trialsConnor Prosty, Khaled Katergi, Mark Sorin, et al.
International Journal of Molecular Sciences|February 13, 2025
Markers of Type 2 Inflammation and Immunosenescence Are Upregulated in Localized SclerodermaLauren Khoury, Connor Prosty, Stephanie Ghazal, et al.
Clinical and Experimental Dermatology|May 9, 2024
Prevalence of omalizumab-resistant chronic urticaria and real-world effectiveness of dupilumab in patients with omalizumab-refractory chronic urticaria: a single-centre experienceCatherine Zhu, Hessah BinJadeed, Sofianne Gabrielli, et al.
Frontiers in Medicine|July 25, 2022
<i>In silico</i> Identification of Immune Cell-Types and Pathways Involved in Chronic Spontaneous UrticariaConnor Prosty, Sofianne Gabrielli, Moshe Ben-Shoshan, et al.
JAMA Dermatology|December 10, 2025
Botulinum Toxin for Refractory Digital Ischemia and Ulcers in Systemic Sclerosis: A Systematic Review and Meta-AnalysisCatherine Zhu, Katya Peri, Catherine Silotch, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|September 15, 2022
Observational versus randomized controlled trials to inform antibiotic treatment durations: a narrative reviewEmily G McDonald, Connor Prosty, Ryan Hanula, et al.
The Journal of Allergy and Clinical Immunology. in Practice|August 16, 2022
Validation of the Urticaria Control Test (UCT) in Children With Chronic UrticariaConnor Prosty, Sofianne Gabrielli, Pasquale Mule, et al.
International Archives of Allergy and Immunology|May 19, 2025
Assessment of Quality of Life in Children with Chronic Urticaria using the Children's Dermatology Life Quality Questionnaire Index (CDLQI): A Retrospective Cohort StudyCatherine K Zhu, Noha Benharira, Connor Prosty, et al.
The Journal of Allergy and Clinical Immunology. in Practice|April 10, 2025
Health-Related Quality of Life in Chronic Urticaria: A Systematic Review and Meta-AnalysisGabriel Berberi, Mahan Maazi, Connor Prosty, et al.
Pageof 6

Showing results (21-30 of 56) with videos related to

Sort By:
Pageof 6
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|July 23, 2024
Revisiting the Evidence Base That Informs the Use of Adjunctive Therapy for Enterococcus faecalis Endocarditis: A Systematic Review and Meta-AnalysisConnor Prosty, Mark Sorin, Khaled Katergi, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|April 7, 2024
Comparative efficacy and safety of Pneumocystis jirovecii pneumonia prophylaxis regimens for people living with HIV: a systematic review and network meta-analysis of randomized controlled trialsConnor Prosty, Khaled Katergi, Mark Sorin, et al.
International Journal of Molecular Sciences|February 13, 2025
Markers of Type 2 Inflammation and Immunosenescence Are Upregulated in Localized SclerodermaLauren Khoury, Connor Prosty, Stephanie Ghazal, et al.
Clinical and Experimental Dermatology|May 9, 2024
Prevalence of omalizumab-resistant chronic urticaria and real-world effectiveness of dupilumab in patients with omalizumab-refractory chronic urticaria: a single-centre experienceCatherine Zhu, Hessah BinJadeed, Sofianne Gabrielli, et al.
Frontiers in Medicine|July 25, 2022
<i>In silico</i> Identification of Immune Cell-Types and Pathways Involved in Chronic Spontaneous UrticariaConnor Prosty, Sofianne Gabrielli, Moshe Ben-Shoshan, et al.
JAMA Dermatology|December 10, 2025
Botulinum Toxin for Refractory Digital Ischemia and Ulcers in Systemic Sclerosis: A Systematic Review and Meta-AnalysisCatherine Zhu, Katya Peri, Catherine Silotch, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|September 15, 2022
Observational versus randomized controlled trials to inform antibiotic treatment durations: a narrative reviewEmily G McDonald, Connor Prosty, Ryan Hanula, et al.
The Journal of Allergy and Clinical Immunology. in Practice|August 16, 2022
Validation of the Urticaria Control Test (UCT) in Children With Chronic UrticariaConnor Prosty, Sofianne Gabrielli, Pasquale Mule, et al.
International Archives of Allergy and Immunology|May 19, 2025
Assessment of Quality of Life in Children with Chronic Urticaria using the Children's Dermatology Life Quality Questionnaire Index (CDLQI): A Retrospective Cohort StudyCatherine K Zhu, Noha Benharira, Connor Prosty, et al.
The Journal of Allergy and Clinical Immunology. in Practice|April 10, 2025
Health-Related Quality of Life in Chronic Urticaria: A Systematic Review and Meta-AnalysisGabriel Berberi, Mahan Maazi, Connor Prosty, et al.
Pageof 6